학술논문

Phase I/II study of a peptide-based COVID-19 vaccine to induce T-cell responses against SARS-CoV-2 in cancer patients with B-cell deficiency
Document Type
Journal
Source
ONCOLOGY RESEARCH AND TREATMENT; SEP 2022, 45 SUPPL 2, p262-p263, 2p. Supplement: 2
Subject
Language
English
ISSN
22965262